1. Home
  2. GERN
  3. GERN News

Latest Geron Corporation (GERN) News on November 17, 2025

Arcellx, Inc. (ACLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
GERN

Zacks

17 days ago

Arcellx, Inc. (ACLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Geron (GERN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
GERN

Zacks

18 days ago

Geron (GERN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025
GERN

Business Wire

21 days ago

Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025

When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)?
GERN

Simply Wall St.

a month ago

When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)?

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

5 months ago

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

With 65% institutional ownership, Geron Corporation (NASDAQ:GERN) is a favorite amongst the big guns
GERN

Simply Wall St.

5 months ago

With 65% institutional ownership, Geron Corporation (NASDAQ:GERN) is a favorite amongst the big guns

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program
GERN

Business Wire

6 months ago

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program

Exploring High Growth Tech Stocks In The US May 2025
GERN

Simply Wall St.

6 months ago

Exploring High Growth Tech Stocks In The US May 2025

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

6 months ago

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Why Geron Corporation (GERN) Is The Best Low Priced Biotech Stock to Buy Now
GERN

Insider Monkey

6 months ago

Why Geron Corporation (GERN) Is The Best Low Priced Biotech Stock to Buy Now

GERN

MT Newswires

6 months ago

Scotiabank Downgrades Geron to Sector Perform From Sector Outperform, Adjusts Price Target to $1.50 From $4

Geron Corp (GERN) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges and Strategic ...
GERN

GuruFocus.com

6 months ago

Geron Corp (GERN) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges and Strategic ...

GERN

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Geron Corp Earnings Call

Why Geron Stock Crept Higher Today
GERN

Motley Fool

6 months ago

Why Geron Stock Crept Higher Today

Geron (GERN) Reports Q1 Loss, Lags Revenue Estimates
GERN

Zacks

6 months ago

Geron (GERN) Reports Q1 Loss, Lags Revenue Estimates

GERN

Associated Press Finance

6 months ago

Geron: Q1 Earnings Snapshot

Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights
GERN

Business Wire

6 months ago

Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights

Geron (GERN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
GERN

Zacks

7 months ago

Geron (GERN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Exploring 3 High Growth Tech Stocks In The US Market
GERN

Simply Wall St.

7 months ago

Exploring 3 High Growth Tech Stocks In The US Market

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

7 months ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Is Geron Corp. (NASDAQ:GERN) the Most Promising Penny Stock According to Analysts?
GERN

Insider Monkey

7 months ago

Is Geron Corp. (NASDAQ:GERN) the Most Promising Penny Stock According to Analysts?

Is Geron Corp. (NASDAQ:GERN) the Best Biotech Penny Stock to Buy According to Hedge Funds?
GERN

Insider Monkey

7 months ago

Is Geron Corp. (NASDAQ:GERN) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Should You Invest in Geron Corporation (GERN)?
GERN

Insider Monkey

7 months ago

Should You Invest in Geron Corporation (GERN)?

Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025
GERN

Business Wire

8 months ago

Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025

When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)?
GERN

Simply Wall St.

8 months ago

When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)?

Is Geron Corporation (NASDAQ:GERN)  The Top Penny Stock That Will Skyrocket?
GERN

Insider Monkey

8 months ago

Is Geron Corporation (NASDAQ:GERN)  The Top Penny Stock That Will Skyrocket?

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

8 months ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Is Geron (GERN) Among the Most Oversold Penny Stocks to Buy According to Analysts?
GERN

Insider Monkey

8 months ago

Is Geron (GERN) Among the Most Oversold Penny Stocks to Buy According to Analysts?

GERN

MT Newswires

8 months ago

Sector Update: Health Care Stocks Decline Wednesday Afternoon

GERN

MT Newswires

8 months ago

Sector Update: Health Care Stocks Edge Higher Premarket Wednesday

A new obesity biotech launches; Gilead plans to quickly advance once-yearly PrEP for HIV
GERN

BioPharma Dive

8 months ago

A new obesity biotech launches; Gilead plans to quickly advance once-yearly PrEP for HIV

GERN

MT Newswires

8 months ago

Geron Anemia Treatment Wins European Commission Approval

GERN

MT Newswires

8 months ago

Geron CEO John Scarlett to Depart; Dawn Carter Bir Named in Interim

Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS
GERN

Business Wire

8 months ago

Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS

Geron Corporation Announces Departure of Chief Executive Officer
GERN

Business Wire

8 months ago

Geron Corporation Announces Departure of Chief Executive Officer

High Growth Tech Stocks To Watch In US March 2025
GERN

Simply Wall St.

8 months ago

High Growth Tech Stocks To Watch In US March 2025

James Ziegler Buys Handful Of Shares In Geron
GERN

Simply Wall St.

8 months ago

James Ziegler Buys Handful Of Shares In Geron

Analysts Just Shaved Their Geron Corporation (NASDAQ:GERN) Forecasts Dramatically
GERN

Simply Wall St.

9 months ago

Analysts Just Shaved Their Geron Corporation (NASDAQ:GERN) Forecasts Dramatically

GERN

MT Newswires

9 months ago

B. Riley Downgrades Geron to Neutral From Buy, Cuts Price Target to $2 From $3.50

We Think Geron (NASDAQ:GERN) Can Afford To Drive Business Growth
GERN

Simply Wall St.

9 months ago

We Think Geron (NASDAQ:GERN) Can Afford To Drive Business Growth

Geron Corp (GERN) Q4 2024 Earnings Call Highlights: Strong Cash Position and Rytelo's FDA ...
GERN

GuruFocus.com

9 months ago

Geron Corp (GERN) Q4 2024 Earnings Call Highlights: Strong Cash Position and Rytelo's FDA ...

GERN

Thomson Reuters StreetEvents

9 months ago

Q4 2024 Geron Corp Earnings Call

Why Geron Stock Is Plummeting Today
GERN

Motley Fool

9 months ago

Why Geron Stock Is Plummeting Today

GERN

MT Newswires

9 months ago

Sector Update: Health Care Stocks Decline Late Afternoon

GERN

MT Newswires

9 months ago

Wedbush Lowers Geron's Price Target to $7 From $8, Outperform Rating Maintained

GERN

MT Newswires

9 months ago

Top Midday Decliners

Geron (GERN) Reports Q4 Loss, Tops Revenue Estimates
GERN

Zacks

9 months ago

Geron (GERN) Reports Q4 Loss, Tops Revenue Estimates

GERN

MT Newswires

9 months ago

Geron's Q4 Net Loss Narrows, Revenue Rises

GERN

Associated Press Finance

9 months ago

Geron: Q4 Earnings Snapshot

Geron Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
GERN

Business Wire

9 months ago

Geron Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

Geron to Participate at Upcoming Investor Conferences in March 2025
GERN

Business Wire

9 months ago

Geron to Participate at Upcoming Investor Conferences in March 2025

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

9 months ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GERN

MT Newswires

9 months ago

B. Riley Adjusts Geron Price Target to $3.50 From $5.50, Maintains Buy Rating

Is Geron Corp. (GERN) the Best Nasdaq Stock Under $5 to Buy?
GERN

Insider Monkey

9 months ago

Is Geron Corp. (GERN) the Best Nasdaq Stock Under $5 to Buy?

Geron to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025
GERN

Business Wire

9 months ago

Geron to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

Geron (NASDAQ:GERN) shareholder returns have been stellar, earning 169% in 3 years
GERN

Simply Wall St.

10 months ago

Geron (NASDAQ:GERN) shareholder returns have been stellar, earning 169% in 3 years

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

10 months ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation (GERN) Stock: An Under $5 Gem with Biggest Upside Potential
GERN

Insider Monkey

10 months ago

Geron Corporation (GERN) Stock: An Under $5 Gem with Biggest Upside Potential

Geron Stock Rallies More Than 60% in a Year: Here's Why
GERN

Zacks

10 months ago

Geron Stock Rallies More Than 60% in a Year: Here's Why

Here’s Why Geron Corp. (NASDAQ:GERN) Crashed Today
GERN

Insider Monkey

10 months ago

Here’s Why Geron Corp. (NASDAQ:GERN) Crashed Today

Why Is Geron Corporation (GERN) the Best Long-Term Penny Stock to Buy According to Hedge Funds?
GERN

Insider Monkey

10 months ago

Why Is Geron Corporation (GERN) the Best Long-Term Penny Stock to Buy According to Hedge Funds?

Why GERN Stock (GERN) is Skyrocketing
GERN

Insider Monkey

10 months ago

Why GERN Stock (GERN) is Skyrocketing

Is Geron Corporation (GERN) the Best Penny Stock to Buy for 2025?
GERN

Insider Monkey

a year ago

Is Geron Corporation (GERN) the Best Penny Stock to Buy for 2025?

High Growth Tech Stocks to Watch in December 2024
GERN

Simply Wall St.

a year ago

High Growth Tech Stocks to Watch in December 2024

Why Is Geron Corporation (GERN) Among the Best Biotech Penny Stocks to Invest in Now?
GERN

Insider Monkey

a year ago

Why Is Geron Corporation (GERN) Among the Best Biotech Penny Stocks to Invest in Now?

Geron Corp. (GERN) Ends Trading Week Defying Market Bloodbath
GERN

Insider Monkey

a year ago

Geron Corp. (GERN) Ends Trading Week Defying Market Bloodbath

Is Geron Corp. (GERN) the Biggest Loser of This Week?
GERN

Insider Monkey

a year ago

Is Geron Corp. (GERN) the Biggest Loser of This Week?

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

a year ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation (NASDAQ:GERN) is a favorite amongst institutional investors who own 72%
GERN

Simply Wall St.

a year ago

Geron Corporation (NASDAQ:GERN) is a favorite amongst institutional investors who own 72%

Geron announces positive CHMP opinion for Rytelo
GERN

TipRanks

a year ago

Geron announces positive CHMP opinion for Rytelo

GERN

MT Newswires

a year ago

Geron's Rytelo Secures European Medicines Agency Committee's Approval Recommendation

Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS
GERN

Business Wire

a year ago

Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS

Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue?
GERN

Zacks

a year ago

Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue?

Is Geron Corporation (GERN) the Best NASDAQ Penny Stock to Buy Right Now?
GERN

Insider Monkey

a year ago

Is Geron Corporation (GERN) the Best NASDAQ Penny Stock to Buy Right Now?

Geron Announces New IMerge Analyses Presented at ASH Suggesting Clinical Activity of RYTELO™ (imetelstat) in Patients with Lower-Risk MDS Regardless of Type or Number of Prior Therapies
GERN

Business Wire

a year ago

Geron Announces New IMerge Analyses Presented at ASH Suggesting Clinical Activity of RYTELO™ (imetelstat) in Patients with Lower-Risk MDS Regardless of Type or Number of Prior Therapies

Geron Announces Phase 1 Findings from Two-Part IMproveMF Study Presented at ASH Suggesting Tolerability of RYTELO™ (imetelstat) in Combination with Ruxolitinib as Frontline Therapy in Patients with Myelofibrosis
GERN

Business Wire

a year ago

Geron Announces Phase 1 Findings from Two-Part IMproveMF Study Presented at ASH Suggesting Tolerability of RYTELO™ (imetelstat) in Combination with Ruxolitinib as Frontline Therapy in Patients with Myelofibrosis

Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference
GERN

Business Wire

a year ago

Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Geron Corp. (GERN): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts
GERN

Insider Monkey

a year ago

Geron Corp. (GERN): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

a year ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

High Growth Tech Stocks to Watch in November 2024
GERN

Simply Wall St.

a year ago

High Growth Tech Stocks to Watch in November 2024

Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development
GERN

Business Wire

a year ago

Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development

Geron to Participate in the Stifel 2024 Healthcare Conference
GERN

Business Wire

a year ago

Geron to Participate in the Stifel 2024 Healthcare Conference

Analysts Are Upgrading Geron Corporation (NASDAQ:GERN) After Its Latest Results
GERN

Simply Wall St.

a year ago

Analysts Are Upgrading Geron Corporation (NASDAQ:GERN) After Its Latest Results

Geron Third Quarter 2024 Earnings: Beats Expectations
GERN

Simply Wall St.

a year ago

Geron Third Quarter 2024 Earnings: Beats Expectations

Geron Corp (GERN) Q3 2024 Earnings Call Highlights: Strong Rytelo Launch and Strategic ...
GERN

GuruFocus.com

a year ago

Geron Corp (GERN) Q3 2024 Earnings Call Highlights: Strong Rytelo Launch and Strategic ...

Geron Secures $250M Funding and Strong Q3 Sales
GERN

TipRanks

a year ago

Geron Secures $250M Funding and Strong Q3 Sales

Tezspire succeeds in chronic rhinosinusitis; Gilead writes down Trodelvy value
GERN

BioPharma Dive

a year ago

Tezspire succeeds in chronic rhinosinusitis; Gilead writes down Trodelvy value

Geron (GERN) Q3 2024 Earnings Call Transcript
GERN

Motley Fool

a year ago

Geron (GERN) Q3 2024 Earnings Call Transcript

GERN

MT Newswires

a year ago

Geron Secures up to $375 Million in Funding with Royalty Pharma, Pharmakon Advisors

GERN

MT Newswires

a year ago

Geron's Q3 Loss Narrows, Revenue Increases

Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates
GERN

Zacks

a year ago

Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates

GERN

Associated Press Finance

a year ago

Geron: Q3 Earnings Snapshot

Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million
GERN

GlobeNewswire

a year ago

Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million

Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors
GERN

Business Wire

a year ago

Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors

Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights
GERN

Business Wire

a year ago

Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic Malignancies
GERN

Business Wire

a year ago

Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic Malignancies

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GERN

Business Wire

a year ago

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Is Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds?
GERN

Insider Monkey

a year ago

Is Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds?

GERN

MT Newswires

a year ago

Scotiabank Initiates Geron at Sector Outperform With $6 Price Target

Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024
GERN

Business Wire

a year ago

Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024

Share on Social Networks: